EMA
approval
· 2021-04-23
New treatment for rare autoimmune disease of nerve cells
Summary
EMA announces a new treatment for a rare autoimmune disease affecting nerve cells, representing a regulatory approval or positive decision for a novel therapy i…
Upgrade for the full analysis, importance score, and drug timeline.